Location: Rio De Janeiro, Brazil
CIK: 0001536562 · Show all filings
Period: Q1 2017 (← Previous) (Next →)
Filing Date: May 9, 2017
Total Value: $120M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TR | 200,000 | $47.15M | 39.2% | $235.74 | — | — | Put | 78462F103 |
| KHC | KRAFT HEINZ CO | 506,888 | $46.03M | 38.2% | $90.81 * | $59.21 | +2.4% | COM | 500754106 |
| BUD | ANHEUSER BUSCH INBEV SA/NV | 109,700 | $12.04M | 10.0% | $109.76 | $112.59 | -2.5% | SPONSORED ADR | 03524A108 |
| EWZ | ISHARES | 100,000 | $3.746M | 3.1% | $37.46 | — | — | Call | 464286400 |
| INCY | INCYTE CORP | 15,188 | $2.03M | 1.7% | $133.66 | $94.43 | +41.6% | COM | 45337C102 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 21,624 | $1.898M | 1.6% | $87.77 | $85.05 | +3.2% | COM | 09061G101 |
| — | CELGENE CORP | 14,131 | $1.758M | 1.5% | $124.41 | $99.79 | — | COM | 151020104 |
| UNH | UNITEDHEALTH GROUP INC | 9,772 | $1.603M | 1.3% | $164.04 * | $121.60 | +17.3% | COM | 91324P102 |
| — | ALEXION PHARMACEUTICALS INC | 9,245 | $1.121M | 0.9% | $121.25 | $149.27 | — | COM | 015351109 |
| LLY | LILLY ELI & CO | 7,969 | $670K | 0.6% | $84.08 * | $63.99 | +14.4% | COM | 532457108 |
| REGN | REGENERON PHARMACEUTICALS | 1,179 | $457K | 0.4% | $387.62 | $398.98 | -3.4% | COM | 75886F107 |
| — | TESARO INC | 2,860 | $440K | 0.4% | $153.85 | $142.07 | — | COM | 881569107 |
| — | SEATTLE GENETICS INC | 6,433 | $404K | 0.3% | $62.80 | $52.99 | — | COM | 812578102 |
| EWZ | ISHARES | 10,000 | $375K | 0.3% | $37.50 | — | — | Put | 464286400 |
| VRTX | VERTEX PHARMACEUTICALS INC | 3,339 | $365K | 0.3% | $109.31 | $89.66 | +22.0% | COM | 92532F100 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 6,903 | $299K | 0.2% | $43.31 | $44.87 | -3.5% | COM | 64125C109 |